Yoshiyuki Tokuda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yoshiyuki Tokuda has a total of 186 co-authors. Here are the top co-authors by number of shared publications:
Akihiko Usui
Department of Cardiac Surgery, Nagoya University Graduate School of Medicine
23 shared publicationsTakaaki Sugita
17 shared publicationsHideki Oshima
Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan
16 shared publicationsMasahiko Matsumoto
16 shared publicationsKatsuhiko Matsuyama
15 shared publicationsMasato Mutsuga
Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan
14 shared publications
Latest Publications
- 17 February 2026
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 68 (3)
Left Subclavian Artery Revascularization in Aortic Arch Replacement: Comparative Patency of In Situ Reconstruction and Extra-Anatomic Bypass
Objectives: Revascularization of the left subclavian artery (LSCA) is routinely required during total aortic arch replacement. In situ reconstruction may be technically difficult in cases with large aneurysms or posterior vessel displacement. Extra-anatomic aorto-axillary bypass has been proposed as an alternative, but its long-term patency relative to in situ repair remains uncertain. This study compared LSCA patency between the 2 techniques. Methods: We retrospectively analysed 436 consecutive patients (median age 69.0 years [interquartile range (IQR) 62.0-75.0]; 347 men) who underwent total arch replacement with LSCA revascularization: 240 in situ and 196 extra-anatomic. Postoperative CT imaging (1853 scans; median 3 [IQR 1-6] per patient) was reviewed to determine immediate and long-term patency. Kaplan-Meier analysis was used for time-to-event comparison. A small descriptive subgroup of 18 patients undergoing concomitant left internal thoracic artery (LITA) to left anterior descending artery (LAD) bypass was also reviewed. Results: Perioperative outcomes, including mortality and major complications, were similar between groups. Subclavian wound infection occurred in 3 extra-anatomic cases (1.5%), all managed successfully with local care. Immediate LSCA patency was higher after extra-anatomic bypass (100% vs 92.9%, P < .001). At 5 years, patency remained superior with extra-anatomic bypass (97.7% vs 87.8%; log-rank P = .0002). In the descriptive LITA-LAD subgroup, CT follow-up demonstrated 100% LSCA and LITA graft patency; however, interpretation is limited by the small sample size. Conclusions: Compared with in situ reconstruction, extra-anatomic LSCA bypass provides equivalent perioperative safety and superior long-term patency. These findings support extra-anatomic bypass as a reliable and technically straightforward option for LSCA revascularization during total arch replacement.
- 17 February 2026
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 68 (3)
Left Subclavian Artery Revascularization in Aortic Arch Replacement: Comparative Patency of In Situ Reconstruction and Extra-Anatomic Bypass
Objectives: Revascularization of the left subclavian artery (LSCA) is routinely required during total aortic arch replacement. In situ reconstruction may be technically difficult in cases with large aneurysms or posterior vessel displacement. Extra-anatomic aorto-axillary bypass has been proposed as an alternative, but its long-term patency relative to in situ repair remains uncertain. This study compared LSCA patency between the 2 techniques. Methods: We retrospectively analysed 436 consecutive patients (median age 69.0 years [interquartile range (IQR) 62.0-75.0]; 347 men) who underwent total arch replacement with LSCA revascularization: 240 in situ and 196 extra-anatomic. Postoperative CT imaging (1853 scans; median 3 [IQR 1-6] per patient) was reviewed to determine immediate and long-term patency. Kaplan-Meier analysis was used for time-to-event comparison. A small descriptive subgroup of 18 patients undergoing concomitant left internal thoracic artery (LITA) to left anterior descending artery (LAD) bypass was also reviewed. Results: Perioperative outcomes, including mortality and major complications, were similar between groups. Subclavian wound infection occurred in 3 extra-anatomic cases (1.5%), all managed successfully with local care. Immediate LSCA patency was higher after extra-anatomic bypass (100% vs 92.9%, P < .001). At 5 years, patency remained superior with extra-anatomic bypass (97.7% vs 87.8%; log-rank P = .0002). In the descriptive LITA-LAD subgroup, CT follow-up demonstrated 100% LSCA and LITA graft patency; however, interpretation is limited by the small sample size. Conclusions: Compared with in situ reconstruction, extra-anatomic LSCA bypass provides equivalent perioperative safety and superior long-term patency. These findings support extra-anatomic bypass as a reliable and technically straightforward option for LSCA revascularization during total arch replacement.
- Open Access
- 5 February 2026
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (2)
Do Early Aortic Remodelling Patterns at 6 Months Predict Mid-Term Outcomes After Frozen Elephant Trunk for Chronic Aortic Dissection?
Objectives: To determine whether CT within 6 months after total arch replacement (TAR) with a frozen elephant trunk (FET) for chronic aortic dissection predicts mid-term outcomes and informs the timing of distal treatment. Methods: We analysed 56 consecutive patients who underwent TAR with FET at 2 centres (2009-2022) and had evaluable 6-month postoperative CT. Early remodelling was defined as the change from baseline to 6 months in the maximal outer-to-outer diameter of the proximal descending thoracic aorta at Level A (Ishimaru zone 3, 20 mm distal to the left subclavian artery, measured on centreline-orthogonal reconstructions). Patients were classified as early positive remodelling (EPR; no increase or a decrease) or early negative remodelling (ENR; ≥1-mm increase). Prespecified outcomes were distal aortic reintervention, distal stent graft-induced new entry (dSINE), and overall survival. Results: Mean follow-up was 5.4 years (standard deviation 3.7). Distal reintervention was required in 36/56 patients (64%). At 5 years, freedom from distal reintervention was higher with EPR than with ENR (44.6% vs 6.2%; P = .003). dSINE occurred in 26/56 patients (46.4%); 5-year dSINE-free survival was 65.1% (95% CI, 39.6-81.9) with EPR versus 18.2% (95% CI 5.9-35.2) with ENR (P = .008). Overall, 5-year survival for the cohort was 80.0% (95% CI 64.7-89.2). Among ENR patients, 5-year survival was 0% with conservative management versus 40.5% with distal intervention (P < .001); within EPR, 5-year survival was 65.9% with conservative management versus 85.7% with reintervention (P = .210). Conclusions: A 6-month CT provides simple, actionable risk stratification after TAR with FET for chronic aortic dissection. Absence of EPR identifies a high-risk subgroup (ENR) that warrants closer surveillance and timely distal intervention, optimizing follow-up intensity and treatment timing.
- 5 February 2026
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (2)
Open AccessDo Early Aortic Remodelling Patterns at 6 Months Predict Mid-Term Outcomes After Frozen Elephant Trunk for Chronic Aortic Dissection?
Objectives: To determine whether CT within 6 months after total arch replacement (TAR) with a frozen elephant trunk (FET) for chronic aortic dissection predicts mid-term outcomes and informs the timing of distal treatment. Methods: We analysed 56 consecutive patients who underwent TAR with FET at 2 centres (2009-2022) and had evaluable 6-month postoperative CT. Early remodelling was defined as the change from baseline to 6 months in the maximal outer-to-outer diameter of the proximal descending thoracic aorta at Level A (Ishimaru zone 3, 20 mm distal to the left subclavian artery, measured on centreline-orthogonal reconstructions). Patients were classified as early positive remodelling (EPR; no increase or a decrease) or early negative remodelling (ENR; ≥1-mm increase). Prespecified outcomes were distal aortic reintervention, distal stent graft-induced new entry (dSINE), and overall survival. Results: Mean follow-up was 5.4 years (standard deviation 3.7). Distal reintervention was required in 36/56 patients (64%). At 5 years, freedom from distal reintervention was higher with EPR than with ENR (44.6% vs 6.2%; P = .003). dSINE occurred in 26/56 patients (46.4%); 5-year dSINE-free survival was 65.1% (95% CI, 39.6-81.9) with EPR versus 18.2% (95% CI 5.9-35.2) with ENR (P = .008). Overall, 5-year survival for the cohort was 80.0% (95% CI 64.7-89.2). Among ENR patients, 5-year survival was 0% with conservative management versus 40.5% with distal intervention (P < .001); within EPR, 5-year survival was 65.9% with conservative management versus 85.7% with reintervention (P = .210). Conclusions: A 6-month CT provides simple, actionable risk stratification after TAR with FET for chronic aortic dissection. Absence of EPR identifies a high-risk subgroup (ENR) that warrants closer surveillance and timely distal intervention, optimizing follow-up intensity and treatment timing.
- Open Access
- 5 February 2026
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 38 (1)
Perioperative frailty in nonagenarians undergoing transcatheter aortic valve implantation: a single-center study
Background Transcatheter aortic valve implantation (TAVI) has become an established treatment for severe aortic stenosis (AS) in older patients, including nonagenarians. This study aimed to examine perioperative changes in frailty among nonagenarian patients undergoing TAVI. Methods and results In this single-center observational analysis, 38 consecutive nonagenarian patients (7.3% of 523 TAVI cases) were evaluated. Frailty parameters—including grip strength, cognitive function (MMSE), overall physical performance (SPPB), gait speed, and activities of daily living (Katz index)—were measured before and after the procedure. No significant differences were observed between preoperative and postoperative values for grip strength (17.4 ± 7.1 vs. 16.1 ± 7.4 kgf, p = 0.102), MMSE (24.1 ± 3.9 vs. 24.3 ± 4.6, p = 0.923), or overall SPPB scores (8.7 ± 2.8 vs. 7.5 ± 3.0, p = 0.084). In contrast, gait speed decreased significantly from 0.8 ± 0.3 m/s to 0.7 ± 0.3 m/s (p = 0.001), and the Katz index also showed a small but statistically significant decline (p = 0.042). The proportion of patients with a walking speed below 0.9 m/s did not change significantly (67.6% vs. 83.8%, p = 0.146). Conclusions In a carefully selected nonagenarian cohort, TAVI did not substantially worsen most frailty indices. However, mild in-hospital declines in gait speed and ADL were observed, underscoring the importance of structured early rehabilitation strategies.
- 5 February 2026
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 38 (1)
Open AccessPerioperative frailty in nonagenarians undergoing transcatheter aortic valve implantation: a single-center study
Background Transcatheter aortic valve implantation (TAVI) has become an established treatment for severe aortic stenosis (AS) in older patients, including nonagenarians. This study aimed to examine perioperative changes in frailty among nonagenarian patients undergoing TAVI. Methods and results In this single-center observational analysis, 38 consecutive nonagenarian patients (7.3% of 523 TAVI cases) were evaluated. Frailty parameters—including grip strength, cognitive function (MMSE), overall physical performance (SPPB), gait speed, and activities of daily living (Katz index)—were measured before and after the procedure. No significant differences were observed between preoperative and postoperative values for grip strength (17.4 ± 7.1 vs. 16.1 ± 7.4 kgf, p = 0.102), MMSE (24.1 ± 3.9 vs. 24.3 ± 4.6, p = 0.923), or overall SPPB scores (8.7 ± 2.8 vs. 7.5 ± 3.0, p = 0.084). In contrast, gait speed decreased significantly from 0.8 ± 0.3 m/s to 0.7 ± 0.3 m/s (p = 0.001), and the Katz index also showed a small but statistically significant decline (p = 0.042). The proportion of patients with a walking speed below 0.9 m/s did not change significantly (67.6% vs. 83.8%, p = 0.146). Conclusions In a carefully selected nonagenarian cohort, TAVI did not substantially worsen most frailty indices. However, mild in-hospital declines in gait speed and ADL were observed, underscoring the importance of structured early rehabilitation strategies.
- Open Access
- 1 January 2026
- Published by Editorial Committee of Annals of Thoracic and Cardiovascular Surgery in Annals of Thoracic and Cardiovascular Surgery
- Vol. 32 (1)
Magnesium Administration as a Treatment for Perioperative Atrial Fibrillation following Cardiac Surgery: Safety and Efficacy
Purpose: Atrial fibrillation (AF) is a common complication after cardiac surgery, impacting recovery and outcomes. Magnesium has electrophysiological and rate-controlling effects in AF. This study evaluated the safety and the temporal association between therapeutic intravenous magnesium administration and rhythm outcomes in patients with postoperative atrial fibrillation (POAF) after cardiac surgery.Methods: Between January 2009 and December 2016, 714 patients undergoing cardiac surgery were evaluated. After excluding 49 patients with a history of AF, 130 developed new-onset POAF. Of these, 111 patients (85.4%) received intravenous magnesium according to our institutional protocol, whereas 19 patients (14.6%) did not. Magnesium (20 mEq per dose, 1–3 doses) was administered with other antiarrhythmic agents in 40 patients (36.0%) and as monotherapy in 71 patients (64.0%). The principal efficacy analyses were restricted to the magnesium-monotherapy cohort. Serum magnesium levels after administration were monitored in 35 patients.Results: Among the 71 patients treated with magnesium monotherapy, the heart rate significantly decreased from 114 ± 32.3 bpm to 100 ± 39.7 bpm (P <0.01), with no significant change in blood pressure. Sinus rhythm conversion occurred in 34 patients (47.9%) within 3 hours and in 60 patients (84.5%) within 24 hours. In multivariable logistic regression analysis, a higher preoperative serum magnesium concentration (adjusted OR, 1.31 per 0.1 mg/dL increase; 95% profile-likelihood CI, 1.07–1.65; P = 0.014) and later postoperative onset of POAF (adjusted OR, 1.32 per postoperative day; 95% CI, 1.07–1.68; P = 0.015) were associated with 3-hour conversion. No serious adverse events attributable to magnesium were observed in the monotherapy cohort. However, because no untreated-comparator group was available, spontaneous conversion cannot be distinguished from a treatment effect.Conclusion: Intravenous magnesium monotherapy was associated with heart rate reduction without significant blood pressure deterioration and was followed by early sinus rhythm conversion in a substantial proportion of patients with POAF. These observational findings support the feasibility and apparent safety of this approach, but do not establish a causal antiarrhythmic effect. Prospective controlled studies are required.
- 1 January 2026
- Published by Editorial Committee of Annals of Thoracic and Cardiovascular Surgery in Annals of Thoracic and Cardiovascular Surgery
- Vol. 32 (1)
Open AccessMagnesium Administration as a Treatment for Perioperative Atrial Fibrillation following Cardiac Surgery: Safety and Efficacy
Purpose: Atrial fibrillation (AF) is a common complication after cardiac surgery, impacting recovery and outcomes. Magnesium has electrophysiological and rate-controlling effects in AF. This study evaluated the safety and the temporal association between therapeutic intravenous magnesium administration and rhythm outcomes in patients with postoperative atrial fibrillation (POAF) after cardiac surgery.Methods: Between January 2009 and December 2016, 714 patients undergoing cardiac surgery were evaluated. After excluding 49 patients with a history of AF, 130 developed new-onset POAF. Of these, 111 patients (85.4%) received intravenous magnesium according to our institutional protocol, whereas 19 patients (14.6%) did not. Magnesium (20 mEq per dose, 1–3 doses) was administered with other antiarrhythmic agents in 40 patients (36.0%) and as monotherapy in 71 patients (64.0%). The principal efficacy analyses were restricted to the magnesium-monotherapy cohort. Serum magnesium levels after administration were monitored in 35 patients.Results: Among the 71 patients treated with magnesium monotherapy, the heart rate significantly decreased from 114 ± 32.3 bpm to 100 ± 39.7 bpm (P <0.01), with no significant change in blood pressure. Sinus rhythm conversion occurred in 34 patients (47.9%) within 3 hours and in 60 patients (84.5%) within 24 hours. In multivariable logistic regression analysis, a higher preoperative serum magnesium concentration (adjusted OR, 1.31 per 0.1 mg/dL increase; 95% profile-likelihood CI, 1.07–1.65; P = 0.014) and later postoperative onset of POAF (adjusted OR, 1.32 per postoperative day; 95% CI, 1.07–1.68; P = 0.015) were associated with 3-hour conversion. No serious adverse events attributable to magnesium were observed in the monotherapy cohort. However, because no untreated-comparator group was available, spontaneous conversion cannot be distinguished from a treatment effect.Conclusion: Intravenous magnesium monotherapy was associated with heart rate reduction without significant blood pressure deterioration and was followed by early sinus rhythm conversion in a substantial proportion of patients with POAF. These observational findings support the feasibility and apparent safety of this approach, but do not establish a causal antiarrhythmic effect. Prospective controlled studies are required.
- Open Access
- 16 December 2024
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 67 (1)
Impact of direct mesenteric perfusion on malperfusion in acute type A aortic dissection repair
OBJECTIVES: Mesenteric malperfusion in acute aortic dissection remains a life-threatening complication with no standardized treatment strategy. This study aimed to describe and evaluate the outcomes of our integrated approach combining exploratory laparotomy, immediate mesenteric reperfusion, and central aortic repair. METHODS: We retrospectively reviewed patients with acute aortic dissection with a preoperative diagnosis of mesenteric malperfusion who were treated between August 2011 and November 2022. Our surgical approach was to establish cardiopulmonary bypass, followed by exploratory laparotomy with mesenteric artery flow assessment using Doppler ultrasound and direct perfusion if needed, central aortic repair, and subsequent mesenteric artery reconstruction. The primary end-point was the 30-day operative mortality. RESULTS: Among 217 patients with acute aortic dissection, 12 (5.5%) had mesenteric malperfusion on preoperative computed tomography. Ten patients underwent exploratory laparotomy, where Doppler ultrasonography revealed reduced mesenteric blood flow in five patients (2.3% of the total 217 patients). These patients underwent direct perfusion of the mesenteric artery via a side branch of the cardiopulmonary bypass circuit. Doppler ultrasound confirmed the restoration of mesenteric blood flow in all perfused patients. No bowel resections were required. The operative mortality in patients with mesenteric malperfusion was 20%. The causes of death were stroke (n = 1) and acute myocardial infarction (n = 1). CONCLUSIONS: Our integrated surgical strategy combining central aortic repair with concurrent exploratory laparotomy and immediate mesenteric perfusion demonstrated technical feasibility in managing mesenteric malperfusion during aortic repair. Further prospective studies with larger cohorts are warranted to validate these findings.
- 16 December 2024
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 67 (1)
Open AccessImpact of direct mesenteric perfusion on malperfusion in acute type A aortic dissection repair
OBJECTIVES: Mesenteric malperfusion in acute aortic dissection remains a life-threatening complication with no standardized treatment strategy. This study aimed to describe and evaluate the outcomes of our integrated approach combining exploratory laparotomy, immediate mesenteric reperfusion, and central aortic repair. METHODS: We retrospectively reviewed patients with acute aortic dissection with a preoperative diagnosis of mesenteric malperfusion who were treated between August 2011 and November 2022. Our surgical approach was to establish cardiopulmonary bypass, followed by exploratory laparotomy with mesenteric artery flow assessment using Doppler ultrasound and direct perfusion if needed, central aortic repair, and subsequent mesenteric artery reconstruction. The primary end-point was the 30-day operative mortality. RESULTS: Among 217 patients with acute aortic dissection, 12 (5.5%) had mesenteric malperfusion on preoperative computed tomography. Ten patients underwent exploratory laparotomy, where Doppler ultrasonography revealed reduced mesenteric blood flow in five patients (2.3% of the total 217 patients). These patients underwent direct perfusion of the mesenteric artery via a side branch of the cardiopulmonary bypass circuit. Doppler ultrasound confirmed the restoration of mesenteric blood flow in all perfused patients. No bowel resections were required. The operative mortality in patients with mesenteric malperfusion was 20%. The causes of death were stroke (n = 1) and acute myocardial infarction (n = 1). CONCLUSIONS: Our integrated surgical strategy combining central aortic repair with concurrent exploratory laparotomy and immediate mesenteric perfusion demonstrated technical feasibility in managing mesenteric malperfusion during aortic repair. Further prospective studies with larger cohorts are warranted to validate these findings.
- 1 May 2022
- Published by Elsevier in Journal of Cardiology
- Vol. 79 (5) , 648-654
Albuminuria predicts worsening renal function after transcatheter aortic valve replacement
- 1 May 2022
- Published by Elsevier in Journal of Cardiology
- Vol. 79 (5) , 648-654
Albuminuria predicts worsening renal function after transcatheter aortic valve replacement
- 17 November 2021
- Published by Springer Nature in Surgery Today
- Vol. 52 (7) , 1016-1022
Multidisciplinary surgical approach for renal cell carcinoma with inferior vena cava tumor thrombus
Purposes The optimal surgical management of renal cell carcinoma with tumor thrombus within the inferior vena cava (IVC) remains to be clarified. Methods Sixteen consecutive cases were reviewed. Incision, the IVC clamping position, and the venous drainage procedure were modified according to the tumor thrombus extension level: level I or II (below the hepatic vein, n = 8), level III (above the hepatic vein but below the right atrium, n = 5), and level IV (extending into the right atrium, n = 3). Results For level I or II, resection could be simply achieved by clamping the IVC below the hepatic vein, without hemodynamic collapse. For level III, clamping the IVC above the hepatic vein and the hepatoduodenal ligament was required. Venous drainage from the lower body (cannulation to distal IVC) and portal system (cannulation to ileocolic vein) were applied. When opening the IVC, the significant backflow was controlled using cardiopulmonary bypass with drop-in suckers. For level IV, median sternotomy, exposure of the right atrium, and cardiopulmonary bypass were mandatory. With the combination of these approaches, the perioperative mortality rate was 0% and the 5-year overall survival rate was 52%. Conclusions A multidisciplinary surgical approach is essential, especially for level III and IV cases.
- 17 November 2021
- Published by Springer Nature in Surgery Today
- Vol. 52 (7) , 1016-1022
Multidisciplinary surgical approach for renal cell carcinoma with inferior vena cava tumor thrombus
Purposes The optimal surgical management of renal cell carcinoma with tumor thrombus within the inferior vena cava (IVC) remains to be clarified. Methods Sixteen consecutive cases were reviewed. Incision, the IVC clamping position, and the venous drainage procedure were modified according to the tumor thrombus extension level: level I or II (below the hepatic vein, n = 8), level III (above the hepatic vein but below the right atrium, n = 5), and level IV (extending into the right atrium, n = 3). Results For level I or II, resection could be simply achieved by clamping the IVC below the hepatic vein, without hemodynamic collapse. For level III, clamping the IVC above the hepatic vein and the hepatoduodenal ligament was required. Venous drainage from the lower body (cannulation to distal IVC) and portal system (cannulation to ileocolic vein) were applied. When opening the IVC, the significant backflow was controlled using cardiopulmonary bypass with drop-in suckers. For level IV, median sternotomy, exposure of the right atrium, and cardiopulmonary bypass were mandatory. With the combination of these approaches, the perioperative mortality rate was 0% and the 5-year overall survival rate was 52%. Conclusions A multidisciplinary surgical approach is essential, especially for level III and IV cases.
- Open Access
- 8 January 2021
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 36 (3) , 1126-1129
Beating‐heart total arch replacement for an octogenarian patient with severe heart failure
Surgical outcomes of total arch replacement (TAR) have improved dramatically over the last decades. However, patients of advanced age and with a severely reduced cardiac function and an extended aortic arch aneurysm may not be candidates for conventional TAR. Endovascular and hybrid treatment for extended aortic aneurysm have demonstrated lower mortality and morbidity, and considered for the advanced age and high‐risk patients. But endovascular with total de‐branching technique remains challenging with the slightly dilated ascending aorta. Reducing the operation time, cardiac arrest time, and circulatory arrest time should be needed to resolve the problem for the conventional TAR with an advanced age and a severely reduced cardiac function. We herein introduce our surgical technique for the case of an 84‐year‐old man with a severely reduced cardiac function, who was successfully treated with beating heart TAR with minimization of the operation time, cardiac arrest time, and circulatory arrest time.
- 8 January 2021
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 36 (3) , 1126-1129
Open AccessBeating‐heart total arch replacement for an octogenarian patient with severe heart failure
Surgical outcomes of total arch replacement (TAR) have improved dramatically over the last decades. However, patients of advanced age and with a severely reduced cardiac function and an extended aortic arch aneurysm may not be candidates for conventional TAR. Endovascular and hybrid treatment for extended aortic aneurysm have demonstrated lower mortality and morbidity, and considered for the advanced age and high‐risk patients. But endovascular with total de‐branching technique remains challenging with the slightly dilated ascending aorta. Reducing the operation time, cardiac arrest time, and circulatory arrest time should be needed to resolve the problem for the conventional TAR with an advanced age and a severely reduced cardiac function. We herein introduce our surgical technique for the case of an 84‐year‐old man with a severely reduced cardiac function, who was successfully treated with beating heart TAR with minimization of the operation time, cardiac arrest time, and circulatory arrest time.
- Open Access
- 7 October 2020
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 111 (3) , e213-e215
Sutures on the Anterior Mitral Leaflet to Prevent Systolic Anterior Motion
- 7 October 2020
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 111 (3) , e213-e215
Open AccessSutures on the Anterior Mitral Leaflet to Prevent Systolic Anterior Motion